Simonian Nancy A

CIK 0001359574

President & CEODirector

Filings

Latest Mar 2, 2026

Issuers covered

Showing

16 of 16

Page 1

Track record

2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	2	100%	+13.3%	+13.3%	+16.1%	+10.5%
90 days	2	100%	+51.6%	+51.6%	+68.1%	+35.1%
180 days	2	100%	+88.4%	+88.4%	+89.3%	+87.5%
365 days	2	100%	+99.8%	+99.8%	+99.8%	+99.8%

Companies where Simonian Nancy A has filed

Ticker	Issuer	Filings	Last filed
SYRS	Syros Pharmaceuticals, Inc.	11	Dec 4, 2024
SGEN	Seagen Inc.	4	Dec 15, 2023
GENB	Generate Biomedicines, Inc.	1	Mar 2, 2026

16 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Mar 2, 2026	GENBGenerate Biomedicines, Inc.	Holdings only	-	-	-
Dec 4, 2024	SYRSSyros Pharmaceuticals, Inc.	SSale	37,070	$0.2702	$10,016
Nov 27, 2024	SYRSSyros Pharmaceuticals, Inc.	SSale	134,713	$0.2653	$35,739
Nov 4, 2024	SYRSSyros Pharmaceuticals, Inc.	MExercise	40,125	-	-
Jun 7, 2024	SYRSSyros Pharmaceuticals, Inc.	AGrant	4,000	$0.00	$0
Apr 2, 2024	SYRSSyros Pharmaceuticals, Inc.	FTax	14,052	$5.12	$71,946
Dec 15, 2023	SGENSeagen Inc.	DDisposition	62,753	$229.00	$14,370,437
Dec 5, 2023	SYRSSyros Pharmaceuticals, Inc.	Holdings only	-	-	-
Nov 2, 2023	SYRSSyros Pharmaceuticals, Inc.	FTax	13,401	$2.22	$29,750
Jun 2, 2023	SGENSeagen Inc.	AGrant	2,044	$0.00	$0
Apr 4, 2023	SYRSSyros Pharmaceuticals, Inc.	FTax	1,852	$2.58	$4,778
Feb 21, 2023	SYRSSyros Pharmaceuticals, Inc.	Holdings only	-	-	-
May 17, 2022	SGENSeagen Inc.	AGrant	1,503	$0.00	$0
Apr 4, 2022	SYRSSyros Pharmaceuticals, Inc.	FTax	58,883	$1.12	$65,949
Mar 4, 2022	SGENSeagen Inc.	MExercise	25,000	$20.04	$501,000
Feb 17, 2022	SYRSSyros Pharmaceuticals, Inc.	Holdings only	-	-	-

Showing 1-16 of 16

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.